Zentiva appoints Nick Haggar as chief executive

Zentiva appoints Nick Haggar as chief executive
Nick Haggar has worked for GlaxoSmithKline, InsudPharma and Sandoz (photo provided by Zentiva)

21 January 2019 - Deborah Wilkes

European generics and OTC company Zentiva has appointed Nick Haggar as chief executive officer with effect from 11 February 2019.

Haggar joins the Czech-based company from InsudPharma where he has been chief executive officer since 2016. He has also worked for Baxter Healthcare, GlaxoSmithKline, Ranbaxy and Sandoz.

He will be based in Prague and will report to Zentiva's Advisory Committee.

Zentiva is backed by private-equity firm Advent International which acquired the business from Sanofi for EUR1.92 billion (USD2.18 billion) in September 2018.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions

Click tags below for more information on topics:


Back to Industry News

Share this page: